Evidence map›Paper›PMID 26438863›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Disulphide-reduced psoriasin is a human apoptosis-inducing broad-spectrum fungicide.

Kyaw Zaw Hein, Hitoshi Takahashi, Toshiko Tsumori, Yukihiko Yasui, Yasuko Nanjoh, Tetsuo Toga, Zhihong Wu, Joachim Grötzinger, Sascha Jung, Jan Wehkamp and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. The Contribution of Human Antimicrobial Peptides to Fungi.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Antimicrobial Peptides with Anti-International journal of molecular sciences · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. At the metal-metabolite interface inMicrobiology (Reading, England) · 2021
    Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Kyaw Zaw HeinDepartment of Dermatology, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan;
Hitoshi TakahashiDepartment of Dermatology, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan;
Toshiko TsumoriDepartment of Nursing, Faculty of Health and Welfare, Prefectural University of Hiroshima, Mihara 723-0053, Japan; Department of Anatomy and Morphological Neuroscience, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan;
Yukihiko YasuiDepartment of Anatomy and Morphological Neuroscience, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan;
Yasuko NanjohResearch Center, Nihon Nohyaku Co., Ltd., Kawachi-Nagano, Osaka 586-0094, Japan;
Tetsuo TogaResearch Center, Nihon Nohyaku Co., Ltd., Kawachi-Nagano, Osaka 586-0094, Japan;
Zhihong WuDepartment of Dermatology, University-Hospital Schleswig-Holstein, 24105 Kiel, Germany;
Joachim GrötzingerInstitute of Biochemistry, Christian-Albrechts-University, 24098 Kiel, Germany;
Sascha JungInstitute of Biochemistry, Christian-Albrechts-University, 24098 Kiel, Germany;
Jan WehkampDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of Tübingen, 70376 Stuttgart, Germany; Department of Internal Medicine 1, Robert-Bosch Hospital, 70376 Stuttgart, Germany.
Bjoern O SchroederDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of Tübingen, 70376 Stuttgart, Germany;ORCID http://orcid.org/0000-0002-6716-8284
Jens M SchroederDepartment of Dermatology, University-Hospital Schleswig-Holstein, 24105 Kiel, Germany; jschroeder@dermatology.uni-kiel.de emorita@med.shimane-u.ac.jp.
Eishin MoritaDepartment of Dermatology, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan; jschroeder@dermatology.uni-kiel.de emorita@med.shimane-u.ac.jp.
Shimane University · JPChristian-Albrechts-Universität zu Kiel · DENihon Nohyaku (Japan) · JPUniversity Hospital Schleswig-Holstein · DEDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology · DEPrefectural University of Hiroshima · JPRobert Bosch Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The unexpected resistance of psoriasis lesions to fungal infections suggests local production of an antifungal factor. We purified Trichophyton rubrum-inhibiting activity from lesional psoriasis scale extracts and identified the Cys-reduced form of S100A7/psoriasin (redS100A7) as a principal antifungal factor. redS100A7 inhibits various filamentous fungi, including the mold Aspergillus fumigatus, but not Candida albicans. Antifungal activity was inhibited by Zn(2+), suggesting that redS100A7 interferes with fungal zinc homeostasis. Because S100A7-mutants lacking a single cysteine are no longer antifungals, we hypothesized that redS100A7 is acting as a Zn(2+)-chelator. Immunogold electron microscopy studies revealed that it penetrates fungal cells, implicating possible intracellular actions. In support with our hypothesis, the cell-penetrating Zn(2+)-chelator TPEN was found to function as a broad-spectrum antifungal. Ultrastructural analyses of redS100A7-treated T. rubrum revealed marked signs of apoptosis, suggesting that its mode of action is induction of programmed cell death. TUNEL, SYTOX-green analyses, and caspase-inhibition studies supported this for both T. rubrum and A. fumigatus. Whereas redS100A7 can be generated from oxidized S100A7 by action of thioredoxin or glutathione, elevated redS100A7 levels in fungal skin infection indicate induction of both S100A7 and its reducing agent in vivo. To investigate whether redS100A7 and TPEN are antifungals in vivo, we used a guinea pig tinea pedes model for fungal skin infections and a lethal mouse Aspergillus infection model for lung infection and found antifungal activity in both in vivo animal systems. Thus, selective fungal cell-penetrating Zn(2+)-chelators could be useful as an urgently needed novel antifungal therapeutic, which induces programmed cell death in numerous fungi.

Indexed as

AnimalsAntifungal AgentsApoptosisAspergillosisAspergillus fumigatusCandida albicansDisease Models, AnimalDisulfidesGuinea PigsHumansMiceMicrobial Sensitivity TestsOxidation-ReductionS100 Calcium Binding Protein A7S100 ProteinsAntifungal AgentsDisulfidesS100A7 protein, humanS100 Calcium Binding Protein A7S100 Proteinsantifungalepithelial defenseinnate immunitypsoriasinS100A7

Identifiers

PMID26438863
PMCPMC4620902
OpenAlexW1891423731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.